CME · 10-Q · 2026Q3 · Full report
Liquidity and Debt Position
CME GROUP INC. · 2026-10-23 · Importance 15 · Surprise 46 · Matches filing data
Cash and cash equivalents, excluding restricted cash, totaled $2.2 billion at September 30, 2026, down from $4.4 billion at December 31, 2025. Outstanding fixed-rate notes had aggregate par value of $3.45 billion, with maturities from June 2028 through June 2048; no borrowings were outstanding under the $2.3 billion corporate revolving facility or the $7.0 billion clearing-house secured facility. The company had approximately $2.3 billion of excess corporate borrowing capacity and $10.2 billion of guaranty fund contributions available to collateralize the clearing-house facility. S&P rated the company AA- and Moody’s rated it Aa3, both with stable outlooks; the company reported compliance with all debt-facility covenants.
Key facts
- CME Group maintains a 364-day multi-currency revolving secured credit facility providing up to $7.0 billion for certain clearing-house situations, with an option to increase it to $10.0 billion with lender consent. source
- CME Group's cash and cash equivalents, excluding restricted cash, were $2.2 billion at September 30, 2026, compared with $4.4 billion at December 31, 2025. source
- CME Group maintains a $2.3 billion multi-currency revolving senior credit facility maturing in April 2030, with an option to increase it to $3.3 billion with lender consent. source
- At September 30, 2026, $10.2 billion of clearing firm guaranty fund contributions were available to collateralize CME Group's $7.0 billion secured credit facility. source
- If CME Group's ratings are downgraded below investment grade within specified periods due to a change of control, it must offer to repurchase its fixed-rate notes at 101% of principal plus accrued and unpaid interest. source
- CME Group had no borrowings outstanding under its $2.3 billion revolving senior credit facility and had approximately $2.3 billion of excess borrowing capacity for general corporate purposes at September 30, 2026. source
- CME Group had approximately $2.3 billion of excess general-purpose borrowing capacity under its revolving senior credit facility at September 30, 2026. source
- CME Group's fixed-rate notes due September 2043 had $750.0 million par value and a 5.30% stated rate; a forward-starting swap made the effective interest rate 4.73%. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| cash | negative | realized | -1.1% | CME Group's cash and cash equivalents, excluding restricted cash, were $2.2 billion at September 30, 2026, compared with $4.4 billion at… |